Moreover, ZAK expression was upregulated in glioma-exposed endothelial cells (GECs), where it enhanced blood–tumor barrier (BTB) permeability through the phosphorylation of nuclear factor kappa B (NFκB)-p65 [23]. The gene discussed is MAP3K20; the disease is central nervous system cancer.